Premium
Should M itra C lip be preferred over surgery in high‐risk patients with severe MR and CKD ?
Author(s) -
Cilingiroglu Mehmet,
Marmagkiolis Kostas
Publication year - 2015
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.25887
Subject(s) - medicine , mitraclip , mitral regurgitation , cardiology , kidney disease , renal function , stroke (engine) , stroke volume , pooling , surgery , urology , heart failure , ejection fraction , mechanical engineering , engineering , artificial intelligence , computer science
Key Points Severe mitral regurgitation (MR) may lead to worsening renal function due to a decrease in stroke volume, increase in systemic vascular resistance, and venous pooling. Percutaneous treatment with MitraClip seems to improve renal function in certain patient groups. Larger studies are needed to prove that MitraClip is the preferred strategy in patients with severe MR and chronic kidney disease